Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
2026/02/23 | 23 mins.
Dr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress. CME information and select publications here.
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
2026/02/18 | 57 mins.
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations. CME information and select publications here.
Metastatic Bladder Cancer — Rapid Case Review Issue 2
2026/02/17 | 29 mins.
Dr Fern Anari from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Catherine Fahey from the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, present real patient cases on metastatic bladder cancer, with additional commentary from Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York. CME information and select publications here.
Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting
2026/02/16 | 57 mins.
Dr Ritu Salani from the David Geffen School of Medicine at UCLA in Los Angeles, California, reviews datasets from ESMO Congress 2025 relevant to the care of patients with gynecologic cancers. CME information and select publications here.
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review
2026/02/13 | 17 mins.
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025. CME information and select publications here.